Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-EN | Version v5-FR | |
---|---|---|
Language | English | French |
Date Updated | 2019-03-11 | 2019-02-15 |
Drug Identification Number | 02443295 | 02443295 |
Brand name | NXSTAGE PUREFLOW SOLUTION RFP-209-CAN | NXSTAGE PUREFLOW SOLUTION RFP-209-CAN |
Common or Proper name | Hemodialysis Solution | Hemodialysis Solution |
Company Name | NXSTAGE MEDICAL INC | NXSTAGE MEDICAL INC |
Ingredients | SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE | SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
Strength(s) | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G | 8.408G 1.1G 0.102G 0.221G 0.15G 5.552G |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | DIALYSIS | DIALYSIS |
Packaging size | 5 L | 5 L |
ATC code | B05Z | B05Z |
ATC description | HEMODIALYTICS AND HEMOFILTRATES | HEMODIALYTICS AND HEMOFILTRATES |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2019-02-11 | 2019-02-11 |
Estimated end date | Unknown | Unknown |
Actual end date | 2019-03-11 | |
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |